Invention Grant
US09073855B2 BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases
有权
BCL-2选择性细胞凋亡诱导剂用于治疗癌症和免疫疾病
- Patent Title: BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases
- Patent Title (中): BCL-2选择性细胞凋亡诱导剂用于治疗癌症和免疫疾病
-
Application No.: US13839060Application Date: 2013-03-15
-
Publication No.: US09073855B2Publication Date: 2015-07-07
- Inventor: George A. Doherty , Steven W. Elmore , Lisa Hasvold , Laura Hexamer , Robert A. Mantei , Andrew J. Souers , Gerard M. Sullivan , Zhi-Fu Tao , Gary T. Wang , Le Wang , Xilu Wang , Michael D. Wendt , Todd M. Hansen
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: ABBVIE INC.
- Current Assignee: ABBVIE INC.
- Current Assignee Address: US IL North Chicago
- Agency: Jones Day
- Main IPC: C07D401/10
- IPC: C07D401/10 ; C07D213/62 ; C07D307/02 ; C07D215/14 ; C07D209/32 ; C07D211/96 ; C07D213/64 ; C07D215/20 ; C07D217/16 ; C07D231/56 ; C07D235/26 ; C07D249/04 ; C07D295/125 ; C07D295/14 ; C07D309/14 ; C07D401/12 ; C07D405/12 ; C07D417/12 ; A61K31/496 ; A61K31/5377 ; A61K45/06 ; C07D295/13 ; C07D309/08 ; C07D487/04 ; C07D209/20 ; C07D295/155 ; C07D309/32
Abstract:
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 or Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti-apoptotic Bcl-2 protein.
Public/Granted literature
- US20130296295A1 BCL-2 SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES Public/Granted day:2013-11-07
Information query
